The BIOSECURE Act of 2025 prohibits federal agencies from purchasing biotechnology equipment or services from designated "biotechnology companies of concern" and bars federal contracts, loans, and grants to entities using their products, with implementation occurring 60-90 days after regulatory updates. The bill allows limited waivers for national security, overseas healthcare, intelligence operations, and public health emergencies, all requiring Office of Management and Budget approval and congressional notification within 30 days. The legislation establishes an oversight process allowing companies to request removal from the designation list within 90 days and requires the Director of National Intelligence to assess risks from foreign adversaries acquiring American genetic data, with findings due to Congress within 270 days. The bill also mandates annual intelligence reports on misuse of American genetic data by biotechnology firms and provides detailed definitions of relevant terms such as "multiomic data," which encompasses genomic and related biological information. No additional federal funding is required to implement the act's provisions.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.